References
[1] January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. 2014.
[2] Morillo, Carlos, A, et al. Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2).[J]. JAMA: Journal of the American Medical Association, 2014, 311(7):692-699. [3] Kagawa Y, Fujii E, Fujita S, Ito M. Association between left atrial reverse remodeling and maintenance of sinus rhythm after catheter ablation of persistent atrial fibrillation. Heart Vessels. 2020;35:239-45.
[4] Chew D, Piccini JP. Long-term oral anticoagulant after catheter ablation for atrial fibrillation. Europace. 2021.
[5] Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation. 2005;111:1100-5.
[6] 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design %J Heart Rhythm. 2012;9:632-96.
[7] Jianhui Z, Yi W, Kai T, Xiankai L, Wenhui P, Chun L, et al. Association between left atrial size and atrial fibrillation recurrence after single circumferential pulmonary vein isolation: a systematic review and meta-analysis of observational studies. 2012:638-45.
[8] Clementy N, Benhenda N, Piver E, Pierre B, Bernard A, Fauchier L, et al. Serum Galectin-3 Levels Predict Recurrences after Ablation of Atrial Fibrillation. 2016;6:34357.
[9] Wu G, Wang S, Cheng M, Peng B, Liang J, Huang H, et al. The serum matrix metalloproteinase-9 level is an independent predictor of recurrence after ablation of persistent atrial fibrillation. 2016;71:251-6.
[10] Kimura T, Takatsuki S, Inagawa K, Katsumata Y, Nishiyama T, Nishiyama N, et al. Serum Inflammation Markers Predicting Successful Initial Catheter Ablation for Atrial Fibrillation. 2014;23:636-43.
[11] Dal-Bianco JP, Levine RA. Anatomy of the mitral valve apparatus: role of 2D and 3D echocardiography. Cardiol Clin. 2013;31:151-64.
[12] Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30:303-71.
[13] A WAZ, Fase Chair, B DAR, Rdcs, Fase, C ROB, D ES, Elyse Foster FE, F PAG, Fase, et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation. 2017;30:303-71.
[14] A J, Hanley, J B, Radiology MJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. 1982.
[15] Wilber DJ, Pappone C, Neuzil P, De Paola A, Marchlinski F, Natale A,et al.Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation : A randomized controlled trial. 2010;303:333-40.
[16] Santangeli P, Di Biase L, Natale AJCA, Electrophysiology. Ablation Versus Drugs: What Is the Best First-Line Therapy for Paroxysmal Atrial Fibrillation?: Antiarrhythmic Drugs Are Outmoded and Catheter Ablation Should Be the First-Line Option for All Patients With Paroxysmal Atrial Fibrillation: Pro. 2014;7:739-46.
[17] Mesquita J, Ferreira AM, Cavaco D, Moscoso Costa F, Carmo P, Marques H, et al. Development and validation of a risk score for predicting atrial fibrillation recurrence after a first catheter ablation procedure - ATLAS score. Europace. 2018;20:f428-f35.
[18] Kornej J, Hindricks G, Shoemaker MB, Husser D, Arya A, Sommer P, et al. The APPLE score: a novel and simple score for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation. Clin Res Cardiol. 2015;104:871-6.
[19] Winkle RA, Jarman JW, Mead RH, Engel G, Kong MH, Fleming W, et al. Predicting atrial fibrillation ablation outcome: The CAAP-AF score. Heart Rhythm. 2016;13:2119-25.
[20] Jiang H, Wang W, Wang C, Xie X, Hou Y. Association of pre-ablation level of potential blood markers with atrial fibrillation recurrence after catheter ablation: a meta-analysis. Europace. 2017;19:392-400.
[21] Wynn GJ, Das M, Bonnett LJ, Gupta D. Quality-of-life benefits of catheter ablation of persistent atrial fibrillation: a reanalysis of data from the SARA study. Europace. 2015;17:222-4.
[22] Cristina F, Marina A, Simone F, Cristina G, Walter GM, Mara M, et al. Prediction of atrial fibrillation recurrence after cardioversion in patients with left-atrial dilation. 2015:335-41.
[23] David D, Michelson EL, Naito M, Chen CC, Schaffenburg M, Dreifus LS. Diastolic ”locking” of the mitral valve: the importance of atrial systole and intraventricular volume. Circulation. 1983;67:640-5.
[24] Gertz ZM, Raina A, Saghy L, Zado ES, Callans DJ, Marchlinski FE, et al. Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control. J Am Coll Cardiol. 2011;58:1474-81.
[25] Gertz ZM, Raina A, Mountantonakis SE, Zado ES, Callans DJ, Marchlinski FE, Keane MG, Silvestry FE. The impact of mitral regurgitation on patients undergoing catheter ablation of atrial fibrillation. Europace. 2011; 13:1127-1132..
[26] Rosendael PJV, Katsanos S, Kamperidis V, Roos CJ, Scholte AJHA, Schalij MJ, et al. New Insights on Carpentier I Mitral Regurgitation from Multidetector Row Computed Tomography - ScienceDirect. 2014;114:763-8.
[27] Mitral Regurgitation Associated with Mitral Annular Dilation in Patients with Lone Atrial Fibrillation: An Echocardiographic Study. 2009;26:885-9.
[28] L Z, W J, L Z, J G, Y W, Y L, et al. The role of valvular regurgitation in catheter ablation outcomes of patients with long-standing persistent atrial fibrillation. 2014;16:848-54.
[29] Qiao Y, Wu L, Hou B, Sun W, Yao YJM. Functional mitral regurgitation: predictor for atrial substrate remodeling and poor ablation outcome in paroxysmal atrial fibrillation. Medicine (Baltimore). 2016;95:e4333.
[30] Otsuji Y, Kumanohoso T, Yoshifuku S, Matsukida K, Koriyama C, Kisanuki A, et al. Isolated annular dilation does not usually cause important functional mitral regurgitation: comparison between patients with lone atrial fibrillation and those with idiopathic or ischemic cardiomyopathy. J Am Coll Cardiol. 2002;39:1651-6.
[31] Silbiger JJ. Echocardiographic examination of the posterior atrioventricular groove. Echocardiography. 2014;31:223-33.
[32] Silbiger JJ. Mechanistic insights into atrial functional mitral regurgitation: Far more complicated than just left atrial remodeling. Echocardiography. 2019;36:164-9.
[33] Wunderlich NC, Beigel R, Swaans MJ, Ho SY, Siegel RJ. Percutaneous interventions for left atrial appendage exclusion: options, assessment, and imaging using 2D and 3D echocardiography. JACC Cardiovasc Imaging. 2015;8:472-88.
[34] Melduni RM, Malouf JF, Chandrasekaran K, Bruce CJ, White RD, Law KK, et al. New insights into the predictors of left atrial stunning after successful direct-current cardioversion of atrial fibrillation and flutter. J Am Soc Echocardiogr. 2008;21:848-54.
[35] Melduni RM, Lee HC, Bailey KR, Miller FA, Jr., Hodge DO, Seward JB, et al. Real-time physiologic biomarker for prediction of atrial fibrillation recurrence, stroke, and mortality after electrical cardioversion: A prospective observational study. Am Heart J. 2015;170:914-22.
[36] Pálinkás A, Antonielli E, Picano E, Pizzuti A, Varga A, Nyúzó B, et al. Clinical value of left atrial appendage flow velocity for predicting of cardioversion success in patients with non-valvular atrial fibrillation. Eur Heart J. 2001;22:2201-8.
[37] He Y, Zhang B, Zhu F, Hu Z, Zhong J, Zhu W. Transesophageal echocardiography measures left atrial appendage volume and function and predicts recurrence of paroxysmal atrial fibrillation after radiofrequency catheter ablation. Echocardiography. 2018;35:985-90.
[38] Yang Z, Xu M, Zhang C, Liu H, Shao X, Wang Y, et al. A predictive model using left atrial function and B-type natriuretic peptide level in predicting the recurrence of early persistent atrial fibrillation after radiofrequency ablation. Clin Cardiol. 2021;44:407-14.